Delta Development Team Receives $1.57 Million TACFI Funding for Revolutionary Blood Management System

Delta Development Team Receives Significant Funding for Innovative Total Blood System

In an exciting development for military healthcare, the Delta Development Team (DDT) has been awarded a substantial Tactical Funding Increase (TACFI) of $1.57 million. This funding, granted by AFWERX, which is the innovation wing of the U.S. Department of the Air Force, is aimed at propelling forward the Total Blood System (TBS). This advanced system is designed to revolutionize how blood is managed in military settings, particularly during enroute care and battlefield operations.

Partnership for Progress

The TACFI funding marks a significant collaborative effort involving not just DDT, but also the Air Force's 59th Medical Wing's Office of the Chief Scientist, the Center for Sustainment of Trauma and Readiness Skills (C-STARS), and Air Mobility Command. Together, these entities aim to tackle the critical challenges surrounding blood management for military personnel, notably in emergency healthcare situations.

Dr. Debra Niemeyer, Chief Scientist for the 59th Medical Wing, expressed enthusiasm for the TBS, noting its potential to address major inefficiencies in blood storage and transport. Dr. Niemeyer stated, "The Total Blood System will provide an efficient, scalable, and sustainable solution to blood storage and distribution, especially vital in combat zones where timely medical intervention can mean the difference between life and death."

Tackling Key Challenges

Historically, military and emergency healthcare providers have faced significant obstacles regarding blood supply, including the necessity for cold-stored blood, challenges associated with transport durability, and inefficiencies in long-term blood storage. The Total Blood System (TBS) is designed to directly address these challenges by offering a reliable and secure method for blood storage and transport, ultimately improving critical care capabilities in emergency scenarios.

Montgomery Leija, CEO of the Delta Development Team, commented on the honor of receiving this TACFI opportunity: "We are deeply committed to enhancing the TBS technology, which will bolster support for our warfighters while moving towards commercialization. This system has the potential to redefine how blood is stored, transported, and made accessible in emergencies, leading to improved patient outcomes on and off the battlefield."

Next Steps in Development

The TACFI funding will propel DDT into the next phase of the TBS project, encompassing scaling production, expanding research initiatives, and ensuring adherence to safety and regulatory standards. Such steps are vital for crafting a commercially viable medical system that can serve both military and civilian needs.

The implications of this project extend beyond military applications; effective blood management is a critical aspect of emergency medical response for civilian healthcare systems as well. Implementing the Total Blood System could enhance response efforts globally, particularly during crises that require rapid medical attention.

About Delta Development Team

Delta Development Team has established itself as a leader in thermal technology innovations, focusing on the development of advanced medical storage and transport solutions. By prioritizing expert insights and cutting-edge technology, DDT aims to tackle some of the most complex challenges in medical logistics today. More information about their initiatives can be found at deltadevteam.com.

About AFWERX and the Air Force Research Laboratory

AFWERX operates as the innovation engine of the Department of the Air Force, channeling creativity from small business and startups to address significant challenges. In its pursuit to enhance the U.S. defense landscape, AFWERX has propelled over 10,400 contracts focusing on technological transition and operational capability.

The Air Force Research Laboratory plays a crucial role in spearheading scientific research and development for the Air Force, integrating effective technologies across various domains.

Through this collaborative effort, the Delta Development Team is positioned to significantly impact blood management practices, improving outcomes for military personnel and emergency healthcare systems alike.

This funding allocation is a transformational step in advancing DDT's Total Blood System, propelling innovative solutions in critical medical care for military and civilian applications.